Page 10 - Resented News Today

Disclaimer: This document is the English version of the Japanese document released on May 11, 2023. It was translated into English and presented solely for the... | May 24, 2023

-- Phase 2 results for dazodalibep in Sjögren’s syndrome to be presented on June 1, 11:35-11:45 a.m. CEST and June 3, 9:35-9:45 a.m. CEST -- -- Planned presentations illustrate... | May 23, 2023

– Results from the completed Collaborative Health Research Projects study with McMaster University presented at the American Thoracic Society International Conference – – Data... | May 23, 2023

PTCL Corporate Briefing Session For the Year 2022 Presented By: GCFO Nadeem Khan ... | May 23, 2023

PARIS (dpa-AFX) - Sanofi and Regeneron Pharmaceuticals Inc. (REGN) presented positive Phase 3 results evaluating the investigational use of Dupixent (dupilumab) compared to placebo in adults currently

Emerging Artists to perform at Lainey Wilson’s Bell Bottom Barn Dance in Nashville, Tennessee on June 9 & “Ole Red on the Rise Presented by Tractor Supply” at Ole Red Nashville... | May 22, 2023

Dupixent® late-breaking Phase 3 COPD results presented at ATS and simultaneously published in the New England Journal of Medicine Dupixent is the first and only investigational biologic for... | May 21, 2023

Dupixent® (dupilumab) late-breaking Phase 3 COPD results presented at ATS and simultaneously published in the New England Journal of Medicine Dupixent is the first and only investigational biologic

Novel CoFI device found to be safe and highly effective in detecting coronary microvascular obstruction (MVO) in the cathlab immediately after primary PCI CorFlow Therapeutics AG, a clinical-stage

First clinical trial reporting results of an mRNA therapeutic for intracellular protein replacementTo date, mRNA-3927 has been generally well-tolerated at the doses administered, with encouraging early